𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Higher Busulfan Dose Intensity Does Not Improve Outcomes of Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (AHCT) Following Fludarabine/Busulfan/Atg (FBA)-Based Reduced Toxicity Conditioning (RTC)

✍ Scribed by M. Hamadani; M. Craig; J. Abraham; W. Tse; A. Cumpston; L.F. Gibson; S.C. Remick; S. Leadmon; P. Elder; C. Hofmeister; S. Penza; L. Andritsos; W. Blum; D.M. Benson Jr.; S.M. Devine

Book ID
116282390
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
61 KB
Volume
17
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Higher busulfan dose intensity does not
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning
✍ Mehdi Hamadani; Michael Craig; Gary S. Phillips; Jame Abraham; William Tse; Aaro πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 378 KB

## Abstract We evaluated the impact of busulfan dose intensity in patients undergoing reduced toxicity/intensity conditioning allogeneic transplantation in a multicenter retrospective study of 112 consecutive patients. Seventy‐five patients were conditioned with busulfan (0.8 mg/kg/dose IV × 8 dose